JNJ stock: buy or sell
Aug 1st, 2021
JNJ stock brief
- Johnson & Johnson barely changed a 0.01% after hitting all-time highs last Wednesday
- On July 23 broke out above its latest top at $171.67
- Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide.
Should I buy Johnson & Johnson stock?
All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $JNJ stock a buy?
Currently, Johnson & Johnson stock matches one trading strategy:
Uptrend buy setup
Johnson & Johnson stock continues to trend higher since in October 2020 and has marked an amazing 31.36% gain. Price marked a pull back in this uptrend at $161.79 last June, and since then it bounced off a 6.43%. Price just broke out above the buy point at $171.67, but it can be traded. If price goes above $180.25, it would be better to wait to another pullback. If you decide to enter this trade, the suggested stop loss is at $156.94
|Buy setup||Buy point||Stop loss||Risk|
|Uptrend buy setup||$171.67||$156.94||8.58%|
Should I sell Johnson & Johnson stock?
Knowing when to sell a stock is even more difficult than knowing when to buy it. In the same way as when we have to buy shares, deciding when is appropiate to sell is not a whimsy decision, and we must follow our own trading style. When selling, as well as buying, our strategies are very easy to follow and are only valid for selling shares you already own, not for selling short Johnson & Johnson stock
A guiding principle is that you should not hold an operation that yields losses greater than those expected by the time of the buy. When to sell your stock should always be dictated by the stop-loss (automatic or manual)
Is it time to sell Johnson & Johnson stock?
Currently, Johnson & Johnson stock doesn't match any of our preferred sell setups, so if you hold Johnson & Johnson stock and your operation is in profit probably is not time to sell now
Johnson & Johnson ratings
In the last 30 days we couldn't find any rating for Johnson & Johnson
Johnson & Johnson stock analysis
Since in October 2020, Johnson & Johnson has been printing an uptrend that by now marked an amazing 31.36%. The price shows higher highs and higher troughs, and along the way gave some buying opportunities for those who wanted to trade in. Latest pullback was last June, when price bounced at $161.79. On July 23, Johnson & Johnson broke out above its last top ($171.67) offering a good buy point
$JNJ at new All-time Highs
Johnson & Johnson did it again, and reached all-time highs (ATH) last Wednesday at $173.38
Supports and resistances
Price is at all-time highs and there are not upper resistances.
The current supports are:
The actual range between the upper and lower bands is less than 5%, thus meaning that price volatility is at very low levels. Reduced volatility is often the antecedent to a sharp movement (up or down), so we must be alert and manage our buy or sell orders accordingly
Relative strength index
The has been between the the levels of 30 and 70 for some weeks, and therefore, without this indicator really being helpful in making any decisions.
Johnson & Johnson stock price history
Johnson & Johnson went public on Jan 3rd, 1962 at $0.00 per share1. Since then, JNJ stock surged by -, with an average of 0.00% per year. If you had invested thousand dollars in Johnson & Johnson stock on Jan 1962, it would have a value of $inf today.
1: Adjusted price after possible price splits or reverse-splits
Price target for Johnson & Johnson stock
Nobody knows how much a stock will be priced in the future. Banks and financial organisations publish their analysis forecasting how a particular stock will performance in the future.
The following table shows the price forecasts posted by brokerage institutions in the last month. Again, these targets are not direct recommendations for individual traders and must not be trusted blindly.
We don't have any target price published in the last 30 days for Johnson & Johnson.
Earnings and financials
Earnings call was hosted by Johnson & Johnson ($JNJ) in mid-July after posting the financial report. JNJ presented earnings of $2.48 per share on revenue of $23.3 billion. The consensus earnings estimate was $2.27 per share on revenue of $22.2 billion.Same quarter last year, reported EPS was $1.67, so recently reported EPS means an increase of 48.50%. Sales exploded a 27.14% on an annualized basis in the , from $183.4B to $233.1B last quarter.
JNJ ($JNJ) will host the Q3 earnings call next October. Estimated for this quarter is $2.36, compared to $2.48 that was reported for Q2.
Johnson & Johnson performance
|Johnson & Johnson ($JNJ)||4.50%||5.90%||5.50%|
Important note:The viewpoints given in this article are personal and should not be followed as recommendations for you to buy or sell stocks. The author of this report does not know the specific scenarios of the reader, his or her finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Comments are provided for learning motives only
|Friday, July 30th, 2021|
|Day range||$171.84 - $172.98|
|Average true range||$2.36|
|50d mov avg||$167.38|
|100d mov avg||$165.20|
|200d mov avg||$158.50|
|Earnings date||October 19th, 2021|